不能切除的肝细胞癌综合介入治疗初探  

Combinational Intervention Therapy of Unresectable Hepatocellular Carcinoma

作　　者：陆伟[1] 王凤梅[1] 张洪生[1] 李隽[1] 孙金英[1] 李岩[1] 赵新民[1] 钱绍诚[1] 

机构地区：[1]天津市第三中心医院,300170

出　　处：《天津医药》2000年第11期650-651,共2页Tianjin Medical Journal

摘　　要：目的:评价综合介入(肝动脉化疗栓塞联合超声引导下介入)治疗不能手术切除的原发肝癌的疗效。方法:62例不能手术切除的原发肝癌患者分为两组,A组31例行单纯TACE,B组31例行综合介入治疗,于TACE治疗两周后再行超声引导下介入治疗。结果:本组病例全部随访1个月～2年。B组1年、2年的生存率分别为58.06%和38.71%,高于A组的22.58%和9.685(均P<0.01)。结论:对于不能手术切除的肝细胞癌,综合介入治疗的疗效明显优于单纯TACE。To evaluate the effect of the combinational therapy of transcatheter arterial chemo-embolization (TACE) and ultra-sonography guided intervention on unresectable hepatocellular carcinoma (HCC). Methods: Sxty-two patients with unresectable HCC were divided into two groups at random. Group B( n = 31) was treated with combinational intervention therapy. After 2 weeks of TACE .ultrasonography guided intervention therapy was performed for several times. Group A (n = 31) was treated with TACE alone as control. Results: All cases were followed up for 6 months to 2 years. The 1-year and 2-year survival rates in group B (58.06% and 38.17%) were higher than those in group A (22.58% and 9.68%) (all P<0.01).Conclusion:For unresectable HCC,the effect of combinational intervention therapy significantly excels that of TACE alone.

关 键 词：肝细胞癌 介入放射学 肝动脉化疗栓塞 超声引导 

分 类 号：R735.705[医药卫生—肿瘤] R730.55[医药卫生—临床医学]